A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country. Researchers found that, as of July, the national average of Americans with SARS-CoV-2 antibodies was 9.3%.

The researchers also observed racial and economic differences, with residents in predominantly Black and Hispanic neighborhoods two-to-three times more likely than white Americans to have antibodies; the same was true for those in poorer communities, compared to those who are wealthy.

"This research clearly confirms that despite high rates of COVID-19 in the United States, the number of people with antibodies is still low and we haven't come close to achieving herd immunity," Julie Parsonnet, M.D., one of the study’s authors. “Until an effective vaccine is approved, we need to make sure our more vulnerable populations are reached with prevention measures.”

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…